Pretransplant mogamulizumab against ATLL might increase the risk of acute GVHD and non-relapse mortality

Y. Inoue, S. Fuji, R. Tanosaki, T. Fukuda

Research output: Contribution to journalLetterpeer-review

19 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Pretransplant mogamulizumab against ATLL might increase the risk of acute GVHD and non-relapse mortality'. Together they form a unique fingerprint.